KRAS and pancreatic neoplasm: The functional importance of TP53 inactivation for pancreatic cancer formation has been convincingly demonstrated in several genetically engineered mouse models of pancreatic cancer, where loss of p53 cooperates with p16 and K-Ras alterations (Hruban et al, 2006).